Table 5.
Patient | Onset from Initial MDR-E Infection | Infection or Colonization | Type of MDR-E | Mechanisms of MDR-E Resistance | Median (Range) #cgSNP Between Initial and Recurrent Isolates | Outcome of Recurrence |
---|---|---|---|---|---|---|
CR-035 | 483 days | Purulent tracheobronchitis | CR-Kp | KPC-3, ST258 | Initial (n = 1) vs late recurrent (n = 1) strains | No further recurrence |
4 SNP | Alive | |||||
CR-048 | 1213, 1268, 1274, 1304, and 1421 days | Bacteremia and pneumonia | CR-Kp | KPC-3, ST258 | Initial (n = 2) vs late recurrent (n = 1) strains | Persistent colonization and multiple recurrent infections |
12 (11–13) SNP | Died 1422 days after initial infection (died from recurrent infection due to ceftazidime-avibactam–resistant KPC46-Kp) | |||||
CR-038 | 457, 583, 618, and 759 days | Respiratory and urinary colonization | CR-Kp | KPC-3, ST258 | Initial (n = 4) vs late recurrent (n = 3) strains | Multiple recurrent colonization |
5 (1–7) SNP | Alive | |||||
CR-1092 | 191, 338, and 401 days | Respiratory colonization | CR-Kp | KPC-3, ST258 | Initial (n = 1) vs late recurrent (n = 3) strains | Multiple recurrent colonization |
2 (1–4) SNP | Alive | |||||
CR-070 | 285, 911, 957, and 1224 days | Urinary tract infection | CefR-Escherichia coli | CTX-M15 | Initial (n = 2) vs late recurrent (n = 2) strains | Multiple recurrent colonization |
17 (7–18) SNP | Alive | |||||
CR-047 | 202 days | Urinary colonization | CefR-ECC | CefR-ECC | Isolate not available | No further recurrence |
CTX-M-15 and ACT-16 group | Alive |
Late recurrent colonization or infection was defined as >90 days after the initial infection with the same MDR-E.
Abbreviations: CefR-E, third-generation cephalosporin-resistant Enterobacterales; cg, core genome; CR, cephalosporin-resistant; ECC, Enterobacter cloacae complex; Kp, Klebsiella pneumoniae; Klebsiella pneumoniae carbapenemase; MDR-E, multidrug-resistant Enterobacterales; SNP, single-nucleotide polymorphism.